The State Pharmaceutical Company held discussions with the Serum Institute of India, one of the world's largest vaccine manufacturers, to strengthen the system for procuring required vaccines, medicines, and medical equipment for the Maldives.
In a statement, State Pharma said the primary objective of the meeting was to identify and discuss opportunities to further strengthen the reliable supply of required vaccines and other essential pharmaceutical products to the Maldives.
State Pharma stated that during the meeting held as part of the visit to the Maldives by Serum Institute's Director of International Business, Sandeep Muley, extensive discussions took place on strengthening the procurement system for medicines and medical equipment alongside vaccine supply, as well as potential areas for collaboration on public health programs planned for the future.
According to the company, the Serum Institute is one of the largest suppliers of vaccines to programs run with the assistance of the World Health Organization (WHO) and the UN.
State Pharma noted that the company manufactures a wide variety of high-quality vaccines essential for protecting public health.
State Pharma said the meeting marks an important step in the company's ongoing efforts to further strengthen its network of international suppliers and bolster relations with top-tier global pharmaceutical companies.
The company also stated that the overarching purpose of this work is to establish arrangements ensuring that high-quality, safe medicines and vaccines needed by the public are easily available on a sustainable basis without interruption.
State Pharma also signed an agreement last week with a world-renowned company to import medicines to the Maldives. The task of facilitating the supply of high-quality medicines across all regions of the Maldives was contracted to a company named Healthcare Pharmaceuticals Limited (HPL).
Established 30 years ago in Bangladesh, HPL is a company certified by international pharmaceutical regulatory bodies. These include authorities from countries such as the EU, Australia, and Malaysia.



